SYNAPTICS Inc — Director's Dealing 2014

Apr 30, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS INC (SYNA)
CIK: 0000817720
Period of Report: 2014-04-28

Reporting Person: BAYLESS KATHLEEN A (SVP, CFO, Sec. & Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-28	Common Stock	M	10000	$19.40	Acquired	23169	Direct
2014-04-28	Common Stock	S	6200	$62.74	Disposed	16969	Direct
2014-04-28	Common Stock	S	3800	$64.03	Disposed	13169	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-28	Employee Stock Options (Right to Buy)	$19.40	M	10000	Disposed	2019-03-02	Common Stock (10000)	Direct
2014-04-28	Employee Stock Options (Right to Buy)	$61.40	A	5240	Acquired	2021-04-28	Common Stock (5240)	Direct

Footnotes

F1: The shares were sold pursuant to a 10b5-1 Sales Plan dated February 24, 2014.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.46 to $63.32,
inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.57 to $64.57,
inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F4: 25% of the total number of shares subject to the option vested and became exercisable on the twelve month anniversary of the March 2, 2009 vesting commencement date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 2nd day of each month thereafter until fully vested on March 2, 2013.

F5: 1/12th of the total number of shares subject to the option shall vest and become exercisable each quarter following the April 28, 2014 date of grant, until fully vested on April 28, 2017.